0001209191-14-072924.txt : 20141203 0001209191-14-072924.hdr.sgml : 20141203 20141203212422 ACCESSION NUMBER: 0001209191-14-072924 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141201 FILED AS OF DATE: 20141203 DATE AS OF CHANGE: 20141203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC CENTRAL INDEX KEY: 0001008848 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 BUSINESS PHONE: 914-347-4300 MAIL ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COHEN RON CENTRAL INDEX KEY: 0001272354 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50513 FILM NUMBER: 141264983 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS, INC. STREET 2: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-12-01 0 0001008848 ACORDA THERAPEUTICS INC ACOR 0001272354 COHEN RON 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 0 1 0 0 President and CEO Common Stock 2014-12-01 4 M 0 51265 8.14 A 529794 D Common Stock 2014-12-01 4 S 0 34394 35.5918 D 495400 D Employee Stock Option (right to buy) 8.14 2014-12-01 4 M 0 51265 0.00 D 2015-01-01 Common Stock 51265 0 D Exercise and sales pursuant to a 10b5-1 plan. Dr. Cohen exercised 51,265 stock options, all of which were due to expire 1/1/2015 unless exercised. Dr. Cohen sold 19,200 of the resultant shares, the proceeds of which are being used to fund the exercise of the options and the resulting tax liability. In addition, Dr. Cohen vested in 30,384 shares of restricted stock of which he sold 15,194 shares, the proceeds of which are being used to fund the resulting tax liability. A record of all of Dr. Cohen's holdings is available in Acorda's SEC filings. Dr. Cohen retains the majority of the equity he has been granted in the Company since founding Acorda in 1995. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $35.27 to $36.27 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The shares subject to these options vested in installments and were fully vested on 3/01/2009. /s/ Ron Cohen 2014-12-03